Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population
NCT00253240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2018-11-06
Summary
Family physicians are the primary health care providers for complex patients such as persons with serious mental illness. The psychiatric needs of these patients could take attention away from management of health problems and from usual health promotion services. For example, Schizophrenia is associated with a higher than normal incidence of diabetes, and first line treatments of Schizophrenia have also been found to increase risk for diabetes. As such, this high-risk group requires targeted diabetes strategies. In London Ontario, services are provided to this high risk mental health population primarily by two community agencies: The Western Ontario Therapeutic Community Hostel (WOTCH) and the Canadian Mental Health Association (CMHA). Accordingly, the goal of this project is to assess how these patients are currently being managed by their family physicians and to pilot a community-based, multidisciplinary diabetes clinic model within this population. If this delivery model proves feasible and effective, family physicians could be assisted by existing community agencies in the management of their patients' diabetes and patients will receive improved access to this vital multidisciplinary team.
Conditions
- Diabetes Mellitus
- Schizophrenia
- Psychotic Disorders
Interventions
- PROCEDURE
-
Screening
- PROCEDURE
-
Management
Sponsors & Collaborators
-
Ontario Ministry of Health and Long Term Care
collaborator OTHER_GOV -
Western Ontario Therapeutic Community Hostel (WOTCH)
collaborator UNKNOWN -
Canadian Mental Health Association
collaborator OTHER -
London Intercommunity Health Centre (LIHC)
collaborator OTHER -
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
lead OTHER
Principal Investigators
-
David RS Haslam, MSc MD FRCPC · St. Joseph's Health Care London
-
Stewart B Harris, MD MPH CCFP FACPM · Centre for Studies in Family Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-09-30
- Completion
- 2005-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Metformin Treatment on Cognitive Impairment of Schizophrenia
NCT05838573 ·Status: RECRUITING ·Phase: PHASE3
-
Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia
NCT02964923 ·Status: UNKNOWN
-
The Establishment of the Early Intervention Program for Patients With Schizophrenia
NCT00172770 ·Status: UNKNOWN
-
Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome
NCT00018837 ·Status: COMPLETED ·Phase: NA
-
Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.
NCT05939765 ·Status: WITHDRAWN
-
Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients
NCT00501163 ·Status: COMPLETED
-
Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics
NCT00224276 ·Status: COMPLETED
-
Early and Short Psycho-educational Lifestyle Intervention
NCT02657941 ·Status: TERMINATED ·Phase: NA
-
Neuroendocrine and Metabolite Substrates in Schizophrenia
NCT02423096 ·Status: UNKNOWN
-
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
NCT04503954 ·Status: COMPLETED ·Phase: NA
-
Tracking Outcomes in Psychosis
NCT02882204 ·Status: UNKNOWN
-
The Role of Nitric Oxide in Cognition in Schizophrenia
NCT02906553 ·Status: COMPLETED ·Phase: NA
-
Medication Reviews in Severe Mental Illness
NCT05243160 ·Status: COMPLETED ·Phase: NA
-
Impact of Genetic Counseling for Individuals With Mental Illness
NCT00713804 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Membrane Phospholipid and Energy Metabolism in Subjects at High Risk of Psychotic Transition
NCT05865652 ·Status: RECRUITING ·Phase: NA
-
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
NCT00569504 ·Status: UNKNOWN
-
Promoting Cognitive Health in Schizophrenia
NCT05661448 ·Status: RECRUITING ·Phase: NA
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
Sex, Psychopharmacology, and Diabetes
NCT05951660 ·Status: RECRUITING ·Phase: NA
-
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
NCT00222807 ·Status: COMPLETED
-
Coronary Artery Disease in Patients Suffering From Schizophrenia
NCT02885792 ·Status: UNKNOWN ·Phase: NA
-
Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or
NCT02167724 ·Status: COMPLETED ·Phase: NA
-
Psychometric Validation of an Oral Health-related Scale for Quality of Life and Coping in People With Schizophrenia
NCT03699501 ·Status: COMPLETED
-
Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis
NCT01907282 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Outcomes of a Digital Health Support for the Schizophrenia Spectrum
NCT03649815 ·Status: COMPLETED ·Phase: EARLY_PHASE1